Literature DB >> 17436020

Genetic liability to schizophrenia in Oceanic Palau: a search in the affected and maternal generation.

Bernie Devlin1, Lambertus Klei, Marina Myles-Worsley, Josepha Tiobech, Caleb Otto, William Byerley, Kathryn Roeder.   

Abstract

While liability to schizophrenia (Scz) is due to genetic and environmental factors, specific factors are largely unknown. We postulate a two-hit model for Scz, in which initial liability is generated during fetal brain development: this "hit" is precipitated by environmental stressors biologically interacting with maternal genetic vulnerability to the stress. Additional liability to Scz is generated by individual genetic vulnerability. To evaluate these putative levels of vulnerability, we search in the genome of both affected individuals and their mothers for variation that differs, statistically, from that in the general population. For parental analyses, mothers were treated as "affected," rather than their offspring, and the fathers were treated as "controls". We used a sample from the Palauan population: 175 individuals diagnosed with Scz, broadly defined; 87 mothers and 45 fathers of affected individuals. Pedigree and diagnostic data were available on 2,953 living and deceased subjects. DNA from 553 individuals was genotyped for short tandem repeats (STR) spaced approximately every 10 cM across the genome. We tested for association between affection status and STR alleles; such an approach was reasonable, despite the widely spaced markers, because this population has far-ranging linkage disequilibrium (LD). Results for the truly affected individuals were modest, whereas results from the maternal generation were promising. For a recessive model and a test for excess allele matching across mothers, significant findings occurred for D20S481, D10S1221, D6S1021, D13S317, and D18S976. Regions in which at least two adjacent markers produced substantial association statistics include 2p12-11.2, 2q24.1-32.1, 6q12-14.1, 10q23.2-24.21, 12q23.2-24.21 and 17q23.2-23.3.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17436020     DOI: 10.1007/s00439-007-0358-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   5.881


  87 in total

Review 1.  Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics.

Authors:  A G Cardno; I I Gottesman
Journal:  Am J Med Genet       Date:  2000

2.  Does chorionicity or zygosity predict adverse perinatal outcomes in twins?

Authors:  Johanne Dubé; Linda Dodds; B Anthony Armson
Journal:  Am J Obstet Gynecol       Date:  2002-03       Impact factor: 8.661

3.  Obstetric complications and schizophrenia: historical and meta-analytic review.

Authors:  Mary Cannon; Peter B Jones; Robin M Murray
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

4.  Genome-wide scan in a large complex pedigree with predominantly male schizophrenics from the island of Kosrae: evidence for linkage to chromosome 2q.

Authors:  E M Wijsman; E A Rosenthal; D Hall; M L Blundell; C Sobin; S C Heath; R Williams; M J Brownstein; J A Gogos; M Karayiorgou
Journal:  Mol Psychiatry       Date:  2003-07       Impact factor: 15.992

5.  The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study.

Authors:  Emma Nilsson; Helena Salonen Ros; Sven Cnattingius; Paul Lichtenstein
Journal:  BJOG       Date:  2004-03       Impact factor: 6.531

6.  Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.

Authors:  Anne Parle-McDermott; Peadar N Kirke; James L Mills; Anne M Molloy; Christopher Cox; Valerie B O'Leary; Faith Pangilinan; Mary Conley; Laura Cleary; Lawrence C Brody; John M Scott
Journal:  Eur J Hum Genet       Date:  2006-06       Impact factor: 4.246

7.  Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia.

Authors:  T L Petryshen; F A Middleton; A R Tahl; G N Rockwell; S Purcell; K A Aldinger; A Kirby; C P Morley; L McGann; K L Gentile; S G Waggoner; H M Medeiros; C Carvalho; A Macedo; M Albus; W Maier; M Trixler; P Eichhammer; S G Schwab; D B Wildenauer; M H Azevedo; M T Pato; C N Pato; M J Daly; P Sklar
Journal:  Mol Psychiatry       Date:  2005-12       Impact factor: 15.992

8.  DNA polymorphism-diet-cofactor-development hypothesis and the gene-teratogen model for schizophrenia and other developmental disorders.

Authors:  W G Johnson
Journal:  Am J Med Genet       Date:  1999-08-20

9.  Clinical characteristics of mutation carriers in a large family with glucokinase diabetes (MODY2).

Authors:  N Shehadeh; D Bakri; P R Njølstad; R Gershoni-Baruch
Journal:  Diabet Med       Date:  2005-08       Impact factor: 4.359

10.  Linkage analysis of a completely ascertained sample of familial schizophrenics and bipolars from Palau, Micronesia.

Authors:  Lambertus Klei; Silviu-Alin Bacanu; Marina Myles-Worsley; Brandi Galke; Weiting Xie; Josepha Tiobech; Caleb Otto; Kathyrn Roeder; Bernie Devlin; William Byerley
Journal:  Hum Genet       Date:  2005-05-25       Impact factor: 4.132

View more
  6 in total

1.  The α7 nicotinic acetylcholine receptor and the acute stress response: maternal genotype determines offspring phenotype.

Authors:  Melissa L Sinkus; Marianne Z Wamboldt; Amanda Barton; Tasha E Fingerlin; Mark L Laudenslager; Sherry Leonard
Journal:  Physiol Behav       Date:  2010-11-10

2.  Copy number variants for schizophrenia and related psychotic disorders in Oceanic Palau: risk and transmission in extended pedigrees.

Authors:  Nadine Melhem; Frank Middleton; Kathryn McFadden; Lambertus Klei; Stephen V Faraone; Sophia Vinogradov; Josepha Tiobech; Victor Yano; Stevenson Kuartei; Kathryn Roeder; William Byerley; Bernie Devlin; Marina Myles-Worsley
Journal:  Biol Psychiatry       Date:  2011-10-07       Impact factor: 13.382

3.  Population-based study of baseline ethanol consumption and risk of incident essential tremor.

Authors:  E D Louis; J Benito-León; F Bermejo-Pareja
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-04-09       Impact factor: 10.154

4.  Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples.

Authors:  Michael E Talkowski; Lora McClain; Trina Allen; L Dianne Bradford; Monica Calkins; Neil Edwards; Lyudmila Georgieva; Rodney Go; Ruben Gur; Raquel Gur; George Kirov; Kodavali Chowdari; Joseph Kwentus; Paul Lyons; Hader Mansour; Joseph McEvoy; Michael C O'Donovan; Judith O'Jile; Michael J Owen; Alberto Santos; Robert Savage; Draga Toncheva; Gerard Vockley; Joel Wood; Bernie Devlin; Vishwajit L Nimgaonkar
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-06-05       Impact factor: 3.568

5.  Association between the Regulator of G-protein Signaling 9 Gene and Patients with Methamphetamine Use Disorder and Schizophrenia.

Authors:  Y Okahisa; M Kodama; M Takaki; T Inada; N Uchimura; M Yamada; N Iwata; M Iyo; I Sora; N Ozaki; H Ujike
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

6.  Testing for association based on excess allele sharing in a sample of related cases and controls.

Authors:  Lambertus Klei; Kathyrn Roeder
Journal:  Hum Genet       Date:  2007-03-07       Impact factor: 5.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.